The American Psychiatric Association (APA) has updated its Privacy Policy and Terms of Use, including with new information specifically addressed to individuals in the European Economic Area. As described in the Privacy Policy and Terms of Use, this website utilizes cookies, including for the purpose of offering an optimal online experience and services tailored to your preferences.

Please read the entire Privacy Policy and Terms of Use. By closing this message, browsing this website, continuing the navigation, or otherwise continuing to use the APA's websites, you confirm that you understand and accept the terms of the Privacy Policy and Terms of Use, including the utilization of cookies.

×
No Access

Plasma MHPG in depressive disorders and relationship to the dexamethasone suppression test

Published Online:https://doi.org/10.1176/ajp.143.7.846

Plasma levels of 3-methoxy-4-hydroxyphenylglycol (MHPG) were measured in 51 depressed patients and 43 normal control subjects. There were significantly higher plasma MHPG levels in the combined patient group with current or past melancholia (N = 28) than in nonmelancholic (N = 12) or dysthymic (N = 11) patients, in unipolar melancholic (N = 16) versus bipolar melancholic (N = 4) patients, and in patients with a major depressive episode who failed to suppress cortisol after the dexamethasone suppression test (N = 24) versus patients with normal suppression (N = 16). Anxiety symptoms correlated significantly with plasma MHPG levels. These results substantiate previous evidence that dysregulation of the hypothalamic-pituitary-adrenal axis and sympathetic nervous system occur together in a subgroup of depressed patients.

Access content

To read the fulltext, please use one of the options below to sign in or purchase access.